Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Cash from Investing Activities (2016 - 2026)

Protara Therapeutics' Cash from Investing Activities history spans 14 years, with the latest figure at -$14.7 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 74.77% to -$14.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$95.9 million through Mar 2026, down 53.87% year-over-year, with the annual reading at -$139.5 million for FY2025, 828.22% down from the prior year.
  • Cash from Investing Activities came in at -$14.7 million for Q1 2026, up from -$26.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $23.1 million in Q1 2024 to a low of -$58.4 million in Q1 2025.
  • The 5-year median for Cash from Investing Activities is $2.9 million (2024), against an average of -$3.9 million.
  • Year-over-year, Cash from Investing Activities skyrocketed 17701.87% in 2022 and then crashed 1720.48% in 2025.
  • Protara Therapeutics' Cash from Investing Activities stood at -$18.3 million in 2022, then soared by 179.14% to $14.5 million in 2023, then skyrocketed by 54.98% to $22.5 million in 2024, then plummeted by 219.59% to -$26.9 million in 2025, then soared by 45.29% to -$14.7 million in 2026.
  • Per Business Quant, the three most recent readings for TARA's Cash from Investing Activities are -$14.7 million (Q1 2026), -$26.9 million (Q4 2025), and -$6.5 million (Q3 2025).